1st Counsel – Lifestyle
Author:
Nexalin Technology, Inc.
Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment
April 22, 2026
Nexalin Advances FDA Alzheimer’s Strategy Following Landmark Leadership Meetings in the U.S. and China
April 15, 2026
Join Nexalin’s Exclusive Live Investor Webinar and Q&A Session on April 21
April 14, 2026
Nexalin Announces Peer-Reviewed Study Showing the Company’s DIFS™ Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents
April 9, 2026